Tag: Eli Lilly and Company

Donanemab approved by the FDA for the Treatment of Early Symptomatic Alzheimer’s

Research News

Donanemab approved by the FDA for the Treatment of Early Symptomatic Alzheimer’s

03/07/2024 Dementia Researcher

Positive Results on Donanemab Phase 3 Trial Reported

Research News

Positive Results on Donanemab Phase 3 Trial Reported

17/07/2023 Alzheimer's Association

Donanemab Slowed Cognitive & Functional Decline

Science

Donanemab Slowed Cognitive & Functional Decline

03/05/2023 Dementia Researcher

Donanemab Puts Plasma p-Tau, Remote Assessments to the Test

Science

Donanemab Puts Plasma p-Tau, Remote Assessments to the Test

23/11/2021 Dementia Researcher

On Donanemab, Plaques Plummet. Off Donanemab, They Stay Away

Partner Blogs, Science

On Donanemab, Plaques Plummet. Off Donanemab, They Stay Away

18/08/2021 Alz Forum

Clinical Trial Design Is A Two-Way Street

Careers, Dissemination

Clinical Trial Design Is A Two-Way Street

22/06/2018 Dementia Researcher

Translate »